{"name":"Helios Klinik Gotha/Ohrdruf","slug":"helios-klinik-gotha-ohrdruf","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Allogeneic transfusion","genericName":"Allogeneic transfusion","slug":"allogeneic-transfusion","indication":"Treatment of anemia in patients with chronic kidney disease","status":"phase_2"}]}],"pipeline":[{"name":"Allogeneic transfusion","genericName":"Allogeneic transfusion","slug":"allogeneic-transfusion","phase":"phase_2","mechanism":"Allogeneic transfusion involves the transfer of blood components from a donor to a recipient to replace or supplement the recipient's blood supply.","indications":["Treatment of anemia in patients with chronic kidney disease","Treatment of bleeding disorders, such as hemophilia A and B"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}